JP Patent

JP7502584B2 — 骨粗しょう症の予防又は改善をするための分子状水素含有組成物

Assigned to Miz Co Ltd · Expires 2024-06-19 · 2y expired

What this patent protects

Patent listed against Versed.

Drugs covered by this patent

Versed (midazolam) · Generic (originally Roche)

Patent Metadata

Patent number: JP7502584B2
Jurisdiction: JP
Classification: —
Expires: 2024-06-19
Drug substance claim: No
Drug product claim: No
Assignee: Miz Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.